Correction: Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs

Correction: Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-04-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/10/2/e004009corr1.full

Similar Items

Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs
by: Joachim Sieper, et al.
Published: (2024-02-01)

Is neuropathic pain an overlooked symptom in axial spondyloarthritis?
by: Esra Kayacan Erdoğan, et al.
Published: (2022-09-01)

Myofascial Pain Syndrome: A Nociceptive Condition Comorbid with Neuropathic or Nociplastic Pain
by: César Fernández-de-las-Peñas, et al.
Published: (2023-03-01)

Phenotyping Post-COVID Pain as a Nociceptive, Neuropathic, or Nociplastic Pain Condition
by: César Fernández-de-las-Peñas, et al.
Published: (2022-10-01)

Carpal Tunnel Syndrome: Neuropathic Pain Associated or Not with a Nociplastic Condition
by: César Fernández-de-las-Peñas, et al.
Published: (2023-06-01)

Comorbid infections in patients with spondyloarthritis who received modern antirheumatic therapy (preliminary data)
by: M. M. Baranova, et al.
Published: (2022-09-01)

What Do We Know about Nociplastic Pain?
by: Kacper Bułdyś, et al.
Published: (2023-06-01)

Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis
by: Annelies Boonen, et al.
Published: (2023-10-01)

Development of a web-based decision aid for initiating biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in axial spondyloarthritis
by: Astrid van Tubergen, et al.
Published: (2023-04-01)

Landau model for illustrating the learning and unlearning process of nociplastic pain
by: Belén Valenzuela
Published: (2024-02-01)

Characteristics and Outcomes of Patients Receiving Physical Therapy for Low Back Pain with a Nociplastic Pain Presentation: A Secondary Analysis
by: Abigail T. Wilson, et al.
Published: (2023-01-01)

85 Do adolescents with Osgood Schlatter display nociplastic pain manifestations?
by: Sinead Holden, et al.
Published: (2023-02-01)

Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future
by: Jo Nijs, et al.
Published: (2021-07-01)

Pain in axial spondyloarthritis: role of the JAK/STAT pathway
by: Carlo Selmi, et al.
Published: (2024-02-01)

Parabrachial Calca neurons drive nociplasticity
by: Logan F. Condon, et al.
Published: (2024-04-01)

Characterization of Patients With Axial Spondyloarthritis by Enthesitis Presence: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
by: Philip J. Mease, et al.
Published: (2020-07-01)

Implication of the Nociplastic Features for Clinical Diagnosis of Fibromyalgia: Development of the Preliminary Nociplastic‐Based Fibromyalgia Features (NFF) Tool
by: Banafsheh Ghavidel‐Parsa, et al.
Published: (2022-03-01)

Understanding Nociplastic Pain: Building a Bridge between Clinical Psychology and Medicine
by: Federica Galli
Published: (2023-02-01)

Etanercept in axial spondyloarthritis
by: Gui Luo, et al.
Published: (2022-11-01)

«FLARES» IN AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-07-01)

Progression of axial spondyloarthritis
by: Sh. F. Erdes, et al.
Published: (2021-06-01)

Recently introduced definition of “nociplastic pain” by the International Association for the Study of Pain needs better formulation
by: Aydede, M, et al.
Published: (2018)

The method simulating spontaneous pain in patients with nociplastic pain using rats with fibromyalgia-like condition
by: Shigeharu Tanei, et al.
Published: (2020-01-01)

Presence of a neuropathic pain component in patients with chronic pain after gunshot wounds
by: V.R. Horoshko, et al.
Published: (2023-06-01)

Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab
by: A. Egeberg, et al.
Published: (2022-07-01)

HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis
by: Elvira Favoino, et al.
Published: (2021-07-01)

The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials
by: Renaud Felten, et al.
Published: (2023-07-01)

Uncovering the Underworld of Axial Spondyloarthritis
by: Sergio Del Vescovo, et al.
Published: (2023-03-01)

Coxitis in early axial spondyloarthritis
by: E. M. Agafonova, et al.
Published: (2019-10-01)

Axial Spondyloarthritis: An Evolving Concept
by: Nelly Ziadé
Published: (2015-07-01)

Dynamics of T- and B-lymphocytes in patients with rheumatoid arthritis, receiving biological disease-modifying antirheumatic drugs
by: A. V. Martynova, et al.
Published: (2022-02-01)

Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids
by: Ronald van Vollenhoven, et al.
Published: (2018-10-01)

Can Myofascial Trigger Points Involve Nociplastic Pain? A Scoping Review on Animal Models
by: Matuska W, et al.
Published: (2023-11-01)

The Psychosocial Characteristics and Somatosensory Function of Children and Adolescents Who Meet the Criteria for Chronic Nociplastic Pain
by: Ocay DD, et al.
Published: (2023-02-01)

A modified score to identify and discriminate neuropathic pain: a study on the German version of the neuropathic pain symptom inventory (NPSI)
by: Lungenhausen Margitta, et al.
Published: (2011-08-01)

Extracellular matrix protein turnover markers are associated with axial spondyloarthritis—a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain
by: Helena Port, et al.
Published: (2022-06-01)

Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR Study
by: Salvatore D’Angelo, et al.
Published: (2022-06-01)

Novel therapeutic targets in axial spondyloarthritis
by: Worth, C, et al.
Published: (2018)

Etanercept in axial spondyloarthritis – treatment efficacy
by: I. Z. Gaydukova, et al.
Published: (2022-03-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-02-01)